These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23885971)

  • 1. Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres.
    Kao YH; Steinberg JD; Tay YS; Lim GK; Yan J; Townsend DW; Budgeon CA; Boucek JA; Francis RJ; Cheo TS; Burgmans MC; Irani FG; Lo RH; Tay KH; Tan BS; Chow PKh; Satchithanantham S; Tan AE; Ng DC; Goh AS
    EJNMMI Res; 2013 Jul; 3(1):57. PubMed ID: 23885971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
    Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
    J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
    Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS
    J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High quality imaging and dosimetry for yttrium-90 (
    Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An In-House 3D Voxel Dosimetric Tool to Compare Predictive and Post- Treatment Dosimetry in
    Ferrando O; Bampi R; Foppiano F; Ciarmiello A
    Curr Radiopharm; 2023 Jun; 16(3):214-221. PubMed ID: 36790008
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Tabotta F; Gnesin S; Dunet V; Ponti A; Digklia A; Boughdad S; Schaefer N; Prior JO; Villard N; Tsoumakidou G; Denys A; Duran R
    Sci Rep; 2023 Aug; 13(1):13118. PubMed ID: 37573346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
    Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW
    Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting.
    Kao YH; Steinberg JD; Tay YS; Lim GK; Yan J; Townsend DW; Takano A; Burgmans MC; Irani FG; Teo TK; Yeow TN; Gogna A; Lo RH; Tay KH; Tan BS; Chow PKh; Satchithanantham S; Tan AE; Ng DC; Goh AS
    EJNMMI Res; 2013 Jul; 3(1):56. PubMed ID: 23883566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization.
    Kao YH; Magsombol BM; Toh Y; Tay KH; Chow PKh; Goh AS; Ng DC
    EJNMMI Res; 2014; 4():33. PubMed ID: 25024931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 90Y PET-based dosimetry after selective internal radiotherapy treatments.
    D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O
    Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D inpatient dose reconstruction from the PET-CT imaging of 90Y microspheres for metastatic cancer to the liver: feasibility study.
    Fourkal E; Veltchev I; Lin M; Koren S; Meyer J; Doss M; Yu JQ
    Med Phys; 2013 Aug; 40(8):081702. PubMed ID: 23927299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry.
    d'Abadie P; Walrand S; Hesse M; Annet L; Borbath I; Van den Eynde M; Lhommel R; Jamar F
    Nucl Med Commun; 2021 Jul; 42(7):747-754. PubMed ID: 33741864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planning dosimetry for
    Thomas MA; Mahvash A; Abdelsalam M; Kaseb AO; Kappadath SC
    Med Phys; 2020 Oct; 47(10):5333-5342. PubMed ID: 32790882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Voxel-Based Dosimetry for Assessing the Ability of the Body-Surface-Area Model to Predict Delivered Dose and Radioembolization Outcome.
    Kafrouni M; Allimant C; Fourcade M; Vauclin S; Delicque J; Ilonca AD; Guiu B; Manna F; Molinari N; Mariano-Goulart D; Ben Bouallègue F
    J Nucl Med; 2018 Aug; 59(8):1289-1295. PubMed ID: 29545380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. For Hepatocellular Carcinoma Treated with Yttrium-90 Microspheres, Dose Volumetrics on Post-Treatment Bremsstrahlung SPECT/CT Predict Clinical Outcomes.
    Taswell CS; Studenski M; Pennix T; Stover B; Georgiou M; Venkat S; Jones P; Zikria J; Thornton L; Yechieli R; Mohan P; Portelance L; Spieler B
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.
    Garin E; Lenoir L; Rolland Y; Edeline J; Mesbah H; Laffont S; Porée P; Clément B; Raoul JL; Boucher E
    J Nucl Med; 2012 Feb; 53(2):255-63. PubMed ID: 22302962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of voxel-based dosimetry map for predicting response to trans-arterial radioembolization therapy for hepatocellular carcinoma: a pilot study.
    Yoo MY; Paeng JC; Kim HC; Lee MS; Lee JS; Lee DS; Kang KW; Cheon GJ
    Nucl Med Commun; 2021 Dec; 42(12):1396-1403. PubMed ID: 34392298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective internal radiation therapy of hepatic tumors: Morphologic and functional imaging for voxel-based computer-aided dosimetry.
    Skanjeti A; Magand N; Defez D; Tordo J; Rode A; Manichon AF; Hallouard F; Clave-Darcissac C; Dhomps A; Townsend DM; Rubello D; Giammarile F
    Biomed Pharmacother; 2020 Dec; 132():110865. PubMed ID: 33254427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
    Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
    J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    Garin E; Rolland Y; Edeline J; Icard N; Lenoir L; Laffont S; Mesbah H; Breton M; Sulpice L; Boudjema K; Rohou T; Raoul JL; Clement B; Boucher E
    J Nucl Med; 2015 Mar; 56(3):339-46. PubMed ID: 25678490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.